Vivani Medical, Inc. — Director's Dealing 2024

May 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vivani Medical, Inc. (VANI)
CIK: 0001266806
Period of Report: 2024-05-10

Reporting Person: Dwyer Donald (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-10	Common Stock Option	$1.81	A	70000	Acquired	2034-05-09	Common Stock (70000)	Direct
2024-05-10	Restricted Stock Units	$	A	35000	Acquired		Common Stock (35000)	Direct

Footnotes

F1: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

F3: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.